These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 32834018)

  • 1. Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
    Mutisya EM; Mutua G; Nyasani D; Nduta H; Kabuti RW; Muturi-Kioi V; Omosa-Manyonyi G; Abaasa A; Lindan K; Price MA; Kimani J; Anzala AO
    PLoS One; 2020; 15(8):e0238028. PubMed ID: 32834018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contextualizing willingness to participate: recommendations for engagement, recruitment & enrolment of Kenyan MSM in future HIV prevention trials.
    Doshi M; Avery L; Kaddu RP; Gichuhi M; Gakii G; du Plessis E; Dutta S; Khan S; Kimani J; Lorway RR
    BMC Public Health; 2017 May; 17(1):469. PubMed ID: 28521748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya.
    Mutisya EM; Muturi-Kioi V; Abaasa A; Nyasani D; Kabuti RW; Lunani L; Kotikot T; Mundia M; Mutua G; Ombati G; Nduta H; Price MA; Kimani J; Anzala AO
    BMC Public Health; 2022 Dec; 22(1):2385. PubMed ID: 36536335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness of female sex workers in Kampala, Uganda to participate in future HIV vaccine trials: a case control study.
    Mayanja Y; Abaasa A; Namale G; Price MA; Kamali A
    BMC Public Health; 2020 Nov; 20(1):1789. PubMed ID: 33239018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of retention in observational cohorts and nested simulated HIV vaccine efficacy trials in the key populations in Uganda.
    Abaasa A; Todd J; Nash S; Mayanja Y; Kaleebu P; Fast PE; Price M
    BMC Med Res Methodol; 2020 Feb; 20(1):32. PubMed ID: 32050900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recruitment using respondent driven sampling, risk behaviors assessment and willingness of young female sex workers (18-25 years) in Dar Es Salaam, Tanzania to participate in HIV vaccine trials.
    Mbunda T; Tarimo EAM; Bakari M; Sandström E; Kulane A
    BMC Public Health; 2019 Nov; 19(1):1537. PubMed ID: 31796002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
    Nyasani DK; Mutua GN; Sajabi RM; Ng'ang'a JW; Gachie JN; Maina AM; Lusike LL; Anzala AO; Price MA; Manyonyi GO
    PLoS One; 2018; 13(11):e0206656. PubMed ID: 30388145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simulated vaccine efficacy trials to estimate HIV incidence for actual vaccine clinical trials in key populations in Uganda.
    Abaasa A; Nash S; Mayanja Y; Price M; Fast PE; Kamali A; Kaleebu P; Todd J
    Vaccine; 2019 Apr; 37(15):2065-2072. PubMed ID: 30857933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
    Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
    AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV incidence and its associated factors among young adults with multiple sexual partners in Maputo, Mozambique: a vaccine preparedness study.
    Macicame I; Bhatt N; Viegas E; Yates A; Nwoga C; Chissumba RM; Monteiro V; Imbach M; Milazzo M; Li Q; Schech S; Mebrahtu T; Eller LA; Swann E; Michael NL; Robb ML; Crowell TA; Polyak CS; Jani I;
    BMC Public Health; 2024 Oct; 24(1):2692. PubMed ID: 39358725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Willingness to participate in HIV vaccine efficacy trials among high risk men and women from fishing communities along Lake Victoria in Uganda.
    Asiki G; Abaasa A; Ruzagira E; Kibengo F; Bahemuka U; Mulondo J; Seeley J; Bekker LG; Delany S; Kaleebu P; Kamali A
    Vaccine; 2013 Oct; 31(44):5055-61. PubMed ID: 24021306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frontline Health Service Providers' Perspectives on HIV Vaccine Trials among Female Sex Workers and Men Who Have Sex with Men in Karnataka, South India.
    Ramanaik S; McClarty LM; Khan S; Ramesh BM; Doshi M; Becker ML; Lorway RR
    PLoS One; 2015; 10(10):e0141822. PubMed ID: 26517272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok.
    Thienkrua W; Todd CS; Chaikummao S; Sukwicha W; Yafant S; Tippanont N; Varangrat A; Khlaimanee P; Holtz TH
    AIDS Care; 2014; 26(11):1359-69. PubMed ID: 24797186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
    Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
    Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.
    Etcheverry MF; Evans JL; Sanchez E; Mendez-Arancibia E; Meroño M; Gatell JM; Page K; Joseph J
    Hum Vaccin Immunother; 2013 Feb; 9(2):420-9. PubMed ID: 23291931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of propensity score matching to create counterfactual group to assess potential HIV prevention interventions.
    Abaasa A; Mayanja Y; Asiki G; Price MA; Fast PE; Ruzagira E; Kaleebu P; Todd J
    Sci Rep; 2021 Mar; 11(1):7017. PubMed ID: 33782485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to participate in HIV vaccine trials among men who have sex with men in Rio de Janeiro, Brazil. Projeto Praça Onze Study Group.
    Périssé AR; Schechter M; Moreira RI; do Lago RF; Santoro-Lopes G; Harrison LH
    J Acquir Immune Defic Syndr; 2000 Dec; 25(5):459-63. PubMed ID: 11141246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness to participate in HIV vaccine trials among men who have sex with men in Chennai and Mumbai, India: a social ecological approach.
    Chakrapani V; Newman PA; Singhal N; Jerajani J; Shunmugam M
    PLoS One; 2012; 7(12):e51080. PubMed ID: 23226560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acceptability of HIV vaccine trials in high-risk heterosexual cohorts in Mombasa, Kenya.
    Jackson DJ; Martin HL; Bwayo JJ; Nyange PM; Rakwar JP; Kashonga F; Mandaliya K; Ndinya-Achola JO; Kreiss JK
    AIDS; 1995 Nov; 9(11):1279-83. PubMed ID: 8561982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimates of the size of key populations at risk for HIV infection: men who have sex with men, female sex workers and injecting drug users in Nairobi, Kenya.
    Okal J; Geibel S; Muraguri N; Musyoki H; Tun W; Broz D; Kuria D; Kim A; Oluoch T; Raymond HF
    Sex Transm Infect; 2013 Aug; 89(5):366-71. PubMed ID: 23761166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.